Does CABOZANTINIB S-MALATE Cause Myocardial infarction? 122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Myocardial infarction have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.3% of all adverse event reports for CABOZANTINIB S-MALATE.
122
Reports of Myocardial infarction with CABOZANTINIB S-MALATE
0.3%
of all CABOZANTINIB S-MALATE reports
22
Deaths
67
Hospitalizations
How Dangerous Is Myocardial infarction From CABOZANTINIB S-MALATE?
Of the 122 reports, 22 (18.0%) resulted in death, 67 (54.9%) required hospitalization, and 6 (4.9%) were considered life-threatening.
Is Myocardial infarction Listed in the Official Label?
Yes, Myocardial infarction is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Myocardial infarction?
ROSIGLITAZONE (17,018)
TESTOSTERONE (3,396)
ADALIMUMAB (3,214)
SACUBITRIL\VALSARTAN (3,120)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391)
APIXABAN (2,010)
TICAGRELOR (1,749)
LENALIDOMIDE (1,712)
ETANERCEPT (1,693)
METFORMIN\ROSIGLITAZONE (1,640)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Myocardial infarction Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE